[1] |
SIEGEL R L, WAGLE N S, CERCEK A, et al. Colorectal cancer statistics, 2023[J]. CA A Cancer J Clin, 2023, 73(3): 233-254.
|
[2] |
KELLER D S, BERHO M, PEREZ R O, et al. The multidisciplinary management of rectal cancer[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(7): 414-429.
doi: 10.1038/s41575-020-0275-y
pmid: 32203400
|
[3] |
SAUER R, LIERSCH T, MERKEL S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase Ⅲ trial after a median follow-up of 11 years[J]. J Clin Oncol, 2012, 30(16): 1926-1933.
|
[4] |
BODY A, PRENEN H, LAM M, et al. Neoadjuvant therapy for locally advanced rectal cancer: recent advances and ongoing challenges[J]. Clin Colorectal Cancer, 2021, 20(1): 29-41.
|
[5] |
VAN DER VALK M J M, HILLING D E, BASTIAANNET E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study[J]. Lancet, 2018, 391(10139): 2537-2545.
|
[6] |
GARCIA-AGUILAR J, PATIL S, GOLLUB M J, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy[J]. J Clin Oncol, 2022, 40(23): 2546-2556.
|
[7] |
VERHEIJ F S, OMER D M, WILLIAMS H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase Ⅱ OPRA trial[J]. J Clin Oncol, 2024, 42(5): 500-506.
|
[8] |
THOMPSON H M, OMER D M, LIN S, et al. Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial[J]. JAMA Netw Open, 2024, 7(1): e2350903.
|
[9] |
ASNONG A, D’HOORE A, VAN KAMPEN M, et al. The role of pelvic floor muscle training on low anterior resection syndrome: a multicenter randomized controlled trial[J]. Ann Surg, 2022, 276(5): 761-768.
|
[10] |
CERCEK A, FOOTE M B, ROUSSEAU B, et al. Nonoperative management of mismatch repair-deficient tumors[J]. N Engl J Med, 2025, 392(23): 2297-2308.
|
[11] |
LI Y J, PAN C H, GAO Y Y, et al. Total neoadjuvant therapy with PD-1 blockade for high-risk proficient mismatch repair rectal cancer[J]. JAMA Surg, 2024, 159(5): 529-537.
doi: 10.1001/jamasurg.2023.7996
pmid: 38381429
|
[12] |
LIN Z Y, ZHANG P, CHI P, et al. Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase Ⅲ trial[J]. Ann Oncol, 2024, 35(10): 882-891.
|
[13] |
YANG Y C, PANG K, LIN G L, et al. Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial[J]. Nat Med, 2025, 31(2): 449-456.
doi: 10.1038/s41591-024-03360-5
pmid: 39762418
|
[14] |
XIA F, WANG Y Q, WANG H, et al. Randomized phase Ⅱ trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (TORCH)[J]. J Clin Oncol, 2024, 42(28): 3308-3318.
|
[15] |
GERARD J P, BARBET N, SCHIAPPA R, et al. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact X-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2023, 8(4): 356-367.
|
[16] |
XIA F, CHEN Y, WANG Y, et al. Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in proficient mismatch repair or microsatellite stable (pMMR/MSS) low-lying early rectal cancer: preliminary findings from a prospective, multi-center, phase Ⅱ trial (TORCH-E)[J]. Ann Oncol, 2024, 35: S462.
|
[17] |
LI X X, LIANG L, SHI D B, et al. Vessel-centered laparoscopic total mesorectal excision via medial approach[J]. Transl Cancer Res, 2018, 7(3): 744-757.
|
[18] |
李心翔, 李清国. 腹腔镜直肠癌术中左结肠动脉保留的意义[J]. 中华胃肠外科杂志, 2018, 21(3): 272-275.
|
|
LI X X, LI Q G. Significance of the preservation of left colic artery in laparoscopic resection of rectal cancer[J]. Chin J Gastrointest Surg, 2018, 21(3): 272-275.
|
[19] |
《保留左结肠动脉的直肠癌根治术中国专家共识》编审委员会, 中国医师协会肛肠医师分会大肠癌综合治疗组, 中西医结合学会普通外科专业委员会直肠癌防治专家委员会. 保留左结肠动脉的直肠癌根治术中国专家共识(2021版)[J]. 中华胃肠外科杂志, 2021, 24(11): 950-955.
|
|
Editorial Committee of Chinese Expert Consensus on Radical Resection of Rectal Cancer with Preservation of Left Colorectal Artery (2021 edition); Comprehensive Treatment Group of Colorectal Cancer, Anorectal Doctor Branch, Chinese Medical Doctor Association; Expert Committee on Prevention and Treatment of Rectal Cancer, Special Committee for General Surgery, Society of Integrated Traditional Chinese and Western Medicine. Chinese expert consensus on radical resection of rectal cancer with preservation of left colonic artery (2021 edition)[J]. Chin J Gastrointest Surg, 2021, 24(11): 950-955.
|
[20] |
CASSINOTTI E, AL-TAHER M, ANTONIOU S A, et al. European Association for Endoscopic Surgery (EAES) consensus on indocyanine green (ICG) fluorescence-guided surgery[J]. Surg Endosc, 2023, 37(3): 1629-1648.
doi: 10.1007/s00464-023-09928-5
pmid: 36781468
|
[21] |
陈奕宽, 翁俊勇, 李心翔. 荧光腹腔镜技术在结直肠外科的应用现状与进展[J]. 中国普通外科杂志, 2024, 33(10): 1572-1579.
|
|
CHEN Y K, WENG J Y, LI X X. Current status and advances in the application of fluorescence laparoscopy in colorectal surgery[J]. Chin J Gen Surg, 2024, 33(10): 1572-1579.
|
[22] |
ZHUO C H, LIANG L, YING M G, et al. Laparoscopic low anterior resection and eversion technique combined with a nondog ear anastomosis for mid- and distal rectal neoplasms: a preliminary and feasibility study[J]. Medicine (Baltimore), 2015, 94(50): e2285.
|